PMCTPharmaCountry
    Accueil

Actualités réglementaires

Évolutions réglementaires FDA, EMA, TGA et mondiales

#baclofen ×

UPDATED
Actualités réglementaires
28 sept. 2026•1 min de lecture
FDA Approves Manufacturing Supplements for LIORESAL (baclofen) Tablets
The FDA has approved a series of priority manufacturing (CMC) supplement submissions for the discontinued LIORESAL baclofen tablets (10 mg and 20 mg).
UPDATED
Actualités réglementaires
11 sept. 2026•1 min de lecture
FDA Approves ANDA209102 for Generic Baclofen Tablets
The FDA approved ANDA209102 for generic baclofen oral tablets in 5‑20 mg strengths, manufactured by TruPharma, Advagen Pharma and SOLA Pharmaceuticals.